- Home
- BBIO vs NYT Comparison
BBIO vs NYT Comparison
Compare BBIO & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- NYT
- Stock Information
- Founded
- BBIO 2015
- NYT 1851
- Country
- BBIO United States
- NYT United States
- Employees
- BBIO N/A
- NYT N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- NYT Newspapers/Magazines
- Sector
- BBIO Health Care
- NYT Consumer Discretionary
- Exchange
- BBIO Nasdaq
- NYT Nasdaq
- Market Cap
- BBIO 10.4B
- NYT 9.3B
- IPO Year
- BBIO 2019
- NYT N/A
- Fundamental
- Price
- BBIO $61.73
- NYT $61.27
- Analyst Decision
- BBIO Strong Buy
- NYT Hold
- Analyst Count
- BBIO 18
- NYT 5
- Target Price
- BBIO $74.28
- NYT $62.20
- AVG Volume (30 Days)
- BBIO 2.7M
- NYT 1.7M
- Earning Date
- BBIO 10-29-2025
- NYT 11-05-2025
- Dividend Yield
- BBIO N/A
- NYT 1.17%
- EPS Growth
- BBIO N/A
- NYT 20.86
- EPS
- BBIO N/A
- NYT 2.04
- Revenue
- BBIO $353,780,000.00
- NYT $2,722,233,000.00
- Revenue This Year
- BBIO $123.32
- NYT $10.20
- Revenue Next Year
- BBIO $73.46
- NYT $6.28
- P/E Ratio
- BBIO N/A
- NYT $30.05
- Revenue Growth
- BBIO 62.46
- NYT 8.49
- 52 Week Low
- BBIO $21.72
- NYT $44.83
- 52 Week High
- BBIO $69.48
- NYT $62.24
- Technical
- Relative Strength Index (RSI)
- BBIO 59.65
- NYT 74.60
- Support Level
- BBIO $60.23
- NYT $56.48
- Resistance Level
- BBIO $64.44
- NYT $57.34
- Average True Range (ATR)
- BBIO 3.05
- NYT 1.23
- MACD
- BBIO 0.06
- NYT 0.49
- Stochastic Oscillator
- BBIO 53.68
- NYT 92.96
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.